Insiders · Profile

PASSERI DANIEL R

CHIEF EXECUTIVE OFFICER at Cue Biopharma · Director at CURIS. Filing since 7 Aug 2008. CIK 0001190121

CUE Cue Biopharma, Inc. CHIEF EXECUTIVE OFFICER · 7 trades CRIS CURIS INC Director · 19 trades

Company

Date

Role

Action

Shares

Amount

Of holding

CUE Cue Biopharma, Inc.

16 Dec 2024

CHIEF EXECUTIVE OFFICER

Bought

30,000

$30.90K

22.3%

CUE Cue Biopharma, Inc.

14 Aug 2023

CHIEF EXECUTIVE OFFICER

Bought

3,000

$8.58K

2.3%

CUE Cue Biopharma, Inc.

24 Sep 2021

CHIEF EXECUTIVE OFFICER

Bought

3,400

$50.05K

6.5%

CUE Cue Biopharma, Inc.

21 Jun 2019

CEO and President

Bought

1,377

$10.00K

2.7%

CUE Cue Biopharma, Inc.

6 Jun 2019

CEO and President

Bought

3,000

$20.70K

6.3%

CUE Cue Biopharma, Inc.

16 Aug 2018

CEO and President

Bought

6,000

$48.51K

14.4%

CUE Cue Biopharma, Inc.

29 Jun 2018

CEO and President

Bought

1,600

$19.15K

4.0%

30 Dec 2015

Director

Sold, plan not stated

14,400

$43.34K

6.8%

29 Dec 2015

Director

Sold, plan not stated

11,200

$32.59K

5.3%

28 Dec 2015

Director

Sold, plan not stated

11,000

$31.24K

5.2%

24 Dec 2015

Director

Sold, plan not stated

2,600

$7.54K

1.3%

23 Dec 2015

Director

Sold, plan not stated

10,900

$31.61K

5.2%

22 Dec 2015

Director

Sold, plan not stated

38,000

$104.50K

16.0%

21 Dec 2015

Director

Sold, plan not stated

100,000

$287.00K

33.5%

18 Dec 2015

Director

Sold, plan not stated

189,000

$576.45K

48.7%

8 May 2013

CEO and Director

Sold, plan not stated

86,852

$321.35K

30.4%

7 May 2013

CEO and Director

Sold, plan not stated

40,000

$145.20K

16.7%

6 May 2013

CEO and Director

Sold, plan not stated

60,000

$219.60K

21.6%

3 May 2013

CEO and Director

Sold, plan not stated

65,000

$242.45K

30.1%

2 May 2013

CEO and Director

Sold, plan not stated

50,000

$183.00K

24.9%

6 Dec 2012

CEO and Director

Bought

25,000

$75.75K

19.9%

1 May 2012

CEO and Director

Sold, plan not stated

36,000

$172.80K

22.3%

30 Apr 2012

CEO and Director

Sold, plan not stated

74,650

$360.56K

37.3%

31 Mar 2011

CEO and Director

Sold, plan not stated

98,100

$318.83K

60.1%

30 Mar 2011

CEO and Director

Sold, plan not stated

26,900

$87.96K

29.3%

7 Aug 2008

CEO and Director

Bought

20,000

$31.00K

57.1%

26 decisions on file.